BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Genetown

  Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 17, 2022

  Agios Pharmaceuticals, Inc. announced that the company is scheduled to present at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 17, 2022, at 10:30 a.m. ET.

  May 10, 2022

   · 

  1 min read
• Business

  Bio-Path Holdings to Announce First Quarter 2022 Financial Results on May 17, 2022

  Bio-Path Holdings, Inc. announced that it will host a live conference call and audio webcast on Tuesday, May 17, 2022 at 8:30 a.m. ET to report financial results for the first quarter ended March 31, 2022 and to provide a business overview.

  May 10, 2022

   · 

  1 min read
• Business

  Oncorus Announces Appointment of Richard Wanstall as Chief Financial Officer

  Oncorus, Inc., a viral immunotherapy company focused on driving innovation to transform outcomes for cancer patients, announced the appointment of Richard Wanstall as Chief Financial Officer.

  May 10, 2022

   · 

  6 min read
• Business

  Werewolf Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Highlights

  Werewolf Therapeutics, Inc. provided a business update and reported financial results for the quarter ended March 31, 2022.

  May 10, 2022

   · 

  9 min read
• Business

  Aclaris Therapeutics Reports First Quarter 2022 Financial Results and Provides a Corporate Update

  Aclaris Therapeutics, Inc. announced its financial results for the first quarter of 2022 and provided a corporate update.

  May 10, 2022

   · 

  9 min read
• Genetown

  Entrada Therapeutics to Present at H.C. Wainwright Global Investment Conference - May 10, 2022

  Entrada Therapeutics, Inc. announced that Dipal Doshi, President and Chief Executive Officer, will present virtually at the H.C. Wainwright Global Investment Conference.

  May 10, 2022

   · 

  1 min read
• Biotech Bay

  IGM Biosciences to Present at the 2022 RBC Capital Markets Global Healthcare Conference

  IGM Biosciences, Inc. announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the 2022 RBC Capital Markets Global Healthcare Conference on Tuesday, May 17, 2022 at 9:30 a.m. EST in New York.

  May 10, 2022

   · 

  1 min read
• Business

  Anavex Life Sciences Provides Business Update and Reports Fiscal 2022 Second Quarter Financial Results

  Anavex Life Sciences Corp. reported financial results for its fiscal quarter ended March 31, 2022.

  May 10, 2022

   · 

  8 min read
• Business

  Athenex Provides First Quarter 2022 Financial Results and Business Update

  Athenex, Inc. provided a corporate and financial update for the first quarter ended March 31, 2022.

  May 10, 2022

   · 

  12 min read
• Business

  Achilles Therapeutics Reports First Quarter 2022 Financial Results and Recent Business Highlights

  Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced its financial results for the first quarter ended March 31, 2022, and recent business highlights.

  May 10, 2022

   · 

  8 min read